source
- Diabetes cell therapy biotechs Sernova and Seraxis to mergeTwo companies that have spent decades trying to develop cell therapies for diabetes are set to merge, with the aim of working together to take on a market also being pursued by Vertex and CRISPR ...Endpoints · 18m ago↗ source
- Deaths of two Chinese children receiving CRISPR therapy spark safety debateTwo children in China died after receiving experimental CRISPR-based gene therapies, according to a recent report. The fatalities have unsettled researchers in the United States who are developing…